|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
FY2023
12 months to Mar 31, 2023
|
FY2022
12 months to Mar 31, 2022
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments: | |||||
| Depreciation expense | |||||
| Gain on sale of equipment | |||||
| Impairment of intangible assets | |||||
| Impairment of goodwill | |||||
| Impairment of assets held for sale | |||||
| Loss on disposal | |||||
| Stock-based compensation | |||||
| Change in fair value of derivative warrant liabilities | |||||
| Deferred income tax benefit | |||||
| Unrealized foreign exchange (gain) loss | |||||
| Changes in operating assets and liabilities: | |||||
| Receivables | |||||
| Prepaid expenses | |||||
| Trade and other payables | |||||
| Operating lease right of use asset | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Maturity of short-term investments | |||||
| Purchase of short-term investments | |||||
| Purchase of equipment | |||||
| Proceeds from sale of equipment | |||||
| Sale of equipment | |||||
| Net cash provided by investing activities | |||||
| Cash flows from financing activities: | |||||
| Net proceeds from issuance of common shares and warrants from private placement | |||||
| Proceeds from issuance of common shares from exercise of stock options | |||||
| Net proceeds from shares issued under the at-the-market (ATM) program | |||||
| Gross proceeds from issuance of common stock and warrants from private placement | |||||
| Stock issuance costs | |||||
| Proceeds from issuance of common stock from exercise of stock options | |||||
| Proceeds from issuance of common stock from common warrant exercise | |||||
| Net cash provided by financing activities | |||||
| Effect of exchange rate fluctuations on cash and cash equivalents | |||||
| Net decrease in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of year | |||||
| Cash and cash equivalents, end of year | |||||
| Cash and cash equivalents are comprised of: | |||||
| Cash | |||||
| Cash equivalents | |||||
| Supplemental schedule of non-cash financing activities are comprised of: | |||||
| Issuance costs in accounts payable | |||||
| Settlement of derivative warrant liability | |||||
Loading...